Notified body

Last updated
CE Mark Conformite Europeenne (logo).svg
CE Mark

A notified body, in the European Union, is an organisation that has been designated by a member state to assess the conformity of certain products, before being placed on the EU market, with the applicable essential technical requirements. These essential requirements are publicised in European directives or regulations.

Contents

A manufacturer can use voluntarily European harmonised standards to demonstrate that a product complies with some (or all) of the EU essential requirements; alternatively, a notified body assess the conformity to these essential requirements. Conformity assessment can include inspection and examination of a product, its design, and the manufacturing environment and processes associated with it. For example, a notified body may designate that a medical device conforms to the essential requirements of the Medical Devices Regulation (MDR (EU) 2017/745) which defines the applicable legislation, including the general safety and performance requirements, for medical devices. With this type examination certificate, (and ensuring the product also satisfies all other applicable regulations), the manufacturer can generate its declaration of conformity and label the product with the CE Mark, which is required for distribution and sale in the EU. Additionally, the EU member state accrediting the notified body will then inform the European Commission that the product complies with the essential requirements (or not). [1] [2] [3]

More generally, a notified body is an independent, accredited body which is entitled by an authorized accrediting body. Upon definition of standards and regulations, the accrediting body may allow a notified body to provide verification and certification services. These services are meant to ensure and assess compliance to the previously defined regulations, but also to provide an official certification mark or a declaration of conformity. [4] [5]

Criticism and improvement

The notified bodies system used by the European Union has been publicly criticized in some capacity since at least 2008 [6] [7] [8] [9] [10] for issues such as:

Discussion of further expanding coordination groups of notified bodies for different product areas, improving marketing surveillance, and making participation in standardization and coordination activities mandatory began within EU member states. [6] However, more criticism would arise out of the Poly Implant Prothèse (PIP) scandal in early 2010, when media revealed that the French manufacturer of silicone gel breast implants had been using unapproved in-house manufactured industrial-grade instead of medical-grade silicone for most of its implants. Investigators also brought criticism down on notified body TÜV Rheinland for issuing a certificate of quality for a production process that didn't include the in-house industrial-grade silicone. However, TÜV stated "its remit was to check the production process, not the content of the silicone." [7] [11]

The revelation had a ripple effect, causing both more criticism about the responsibilities of notified bodies and the regulatory process in general and more corrective action. The Central Management Committee was created in September 2010 "to develop the effectiveness of the regulatory system on medical devices in the EU by improving decision making among the national regulatory authorities." [7] [12] Then in February 2012, European Health and Consumer Policy Commissioner John Dalli called upon EU member states to take a hard look at the regulatory system, including how notified bodies play a part. His recommendations included properly verifying whether a notified body is capable of accurately assessing medical devices, improving how conformity assessments are conducted, and developing tools to enhance medical device traceability. [13] The European Commission acted, that September revealing its proposed changes to medical device regulation, including expanded requirements on notified bodies, to be published in 2014 and go into effect in 2017. [14] However, the commission also opted to instate additional reforms — separate from its draft regulations — that would go into effect much sooner, asking notified bodies to perform unannounced visits to manufacturers and expand their device testing standards. At the same time the NB-MED (European Forum of Notified Bodies Medical Devices) coordination revised their code of conduct due to criticism. [7] [15]

In late 2013 and early 2014, a French court ordered (and later upheld its decision) that notified body TÜV Rheinland pay restitution to those affected by the PIP scandal. [16] However, this decision and a similar case in Germany has created questions about how much liability should be applied to notified bodies for patient devices found to be dangerous despite previous notified body assessment. The German case against TÜV was dismissed initially and on appeal in district and regional courts, and an appeal to a German federal court resulted in referral of the case to the Court of Justice of the European Union (CJEU) for clarification "on three issues on the interpretation of the Medical Devices Directive." [17] Additionally, the original restitution decision by French courts was appealed and overturned on July 2, 2015, forcing affected patients to return their interim compensation, leaving many patients without recourse. [18]

As of February 2016, the German case is ongoing, waiting for CJEU input. Rudd-Clarke and Page postulated in December 2015 that if "the CJEU decides that notified bodies are under a duty to protect patients, the practical effects could be that the CE certification process slows down, which is likely to have a detrimental impact on the cost for manufacturers of getting a product to market, while notified bodies may face a significantly increased litigation risk for failure to comply with their duties." [3]

Regulations governing medical device manufacturers and Notified Bodies operating in the medical device field were tightened with the Medical Device Regulation of 2017.

Nando database

The European Commission maintains an online database which includes all designated notified bodies: Nando (New Approach Notified and Designated Organisations) Information System. This searchable and publicly available Nando database contains different lists of notified bodies, including the identification number and contact details of each notified body as well as the tasks for which it has been notified. The lists as well as the designated tasks for each notified body are subject to regular update: as the notification of notified bodies (and their withdrawal, suspension, reinstatement) is the responsibility of the notifying EU Member State (and not of the European Commission), the data in this Nando database is provided by the designating authorities of that EU Member States.

The database can be used to verify the status (valid/withdrawn/expired/suspended) of a notified body related to a particular European Directive or Regulation as well as the associated designated scope of tasks related to conformity assessment procedures set out in that Directive or Regulation. [19] [2] ...

See also

Related Research Articles

<span class="mw-page-title-main">Biomedical engineering</span> Application of engineering principles and design concepts to medicine and biology

Biomedical engineering (BME) or medical engineering is the application of engineering principles and design concepts to medicine and biology for healthcare applications. BME is also traditionally logical sciences to advance health care treatment, including diagnosis, monitoring, and therapy. Also included under the scope of a biomedical engineer is the management of current medical equipment in hospitals while adhering to relevant industry standards. This involves procurement, routine testing, preventive maintenance, and making equipment recommendations, a role also known as a Biomedical Equipment Technician (BMET) or as a clinical engineer.

Conformance testing — an element of conformity assessment, and also known as compliance testing, or type testing — is testing or other activities that determine whether a process, product, or service complies with the requirements of a specification, technical standard, contract, or regulation. Testing is often either logical testing or physical testing. The test procedures may involve other criteria from mathematical testing or chemical testing. Beyond simple conformance, other requirements for efficiency, interoperability, or compliance may apply. Conformance testing may be undertaken by the producer of the product or service being assessed, by a user, or by an accredited independent organization, which can sometimes be the author of the standard being used. When testing is accompanied by certification, the products or services may then be advertised as being certified in compliance with the referred technical standard. Manufacturers and suppliers of products and services rely on such certification including listing on the certification body's website, to assure quality to the end user and that competing suppliers are on the same level.

Medical software is any software item or system used within a medical context, such as:reducing the paperwork, tracking patient activity

<span class="mw-page-title-main">CE marking</span> European Declaration of conformity mark

The presence of the logo on commercial products indicates that the manufacturer or importer affirms the goods' conformity with European health, safety, and environmental protection standards. It is not a quality indicator or a certification mark. The CE marking is required for goods sold in the European Economic Area (EEA); goods sold elsewhere may also carry the mark.

<span class="mw-page-title-main">Medical device</span> Device to be used for medical purposes

A medical device is any device intended to be used for medical purposes. Significant potential for hazards are inherent when using a device for medical purposes and thus medical devices must be proved safe and effective with reasonable assurance before regulating governments allow marketing of the device in their country. As a general rule, as the associated risk of the device increases the amount of testing required to establish safety and efficacy also increases. Further, as associated risk increases the potential benefit to the patient must also increase.

The Pressure Equipment Directive (PED) 2014/68/EU of the EU sets out the standards for the design and fabrication of pressure equipment generally over one liter in volume and having a maximum pressure more than 0.5 bar gauge. It also sets the administrative procedures requirements for the "conformity assessment" of pressure equipment, for the free placing on the European market without local legislative barriers. It has been mandatory throughout the EU since 30 May 2002, with 2014 revision fully effective as of 19 July 2016. The standards and regulations regarding pressure vessels and boiler safety are also very close to the US standards defined by the American Society of Mechanical Engineers (ASME). This enables most international inspection agencies to provide both verification and certification services to assess compliance to the different pressure equipment directives. From the pressure vessel manufactures PED does not generally require a prior manufacturing permit/certificate/stamp as ASME does.

Type approval or certificate of conformity is granted to a product that meets a minimum set of regulatory, technical and safety requirements. Generally, type approval is required before a product is allowed to be sold in a particular country, so the requirements for a given product will vary around the world. Processes and certifications known as type approval in English are often called homologation, or some cognate expression, in other European languages.

<span class="mw-page-title-main">Product certification</span> Performance and quality assurance

Product certification or product qualification is the process of certifying that a certain product has passed performance tests and quality assurance tests, and meets qualification criteria stipulated in contracts, regulations, or specifications.

<span class="mw-page-title-main">ATEX directive</span> EU ATEX Directive on workplaces with an explosive atmosphere

The ATEX directives are two EU directives describing the minimum safety requirements for workplaces and equipment used in explosive atmospheres. The name is an initialization of the term ATmosphères EXplosibles.

ISO 13485Medical devices -- Quality management systems -- Requirements for regulatory purposes is a voluntary standard, published by International Organization for Standardization (ISO) for the first time in 1996, and contains a comprehensive quality management system for the design and manufacture of medical devices. The latest version of this standard supersedes earlier documents such as EN 46001 and EN 46002 (1996), the previously published ISO 13485, and ISO 13488.

<span class="mw-page-title-main">Medical Devices Directive</span>

The Medical Device Directive — Council Directive 93/42/EEC of 14 June 1993 concerning medical devices — is intended to harmonise the laws relating to medical devices within the European Union. The MD Directive is a 'New Approach' Directive and consequently in order for a manufacturer to legally place a medical device on the European market the requirements of the MD Directive have to be met. Manufacturers' products meeting 'harmonised standards' have a presumption of conformity to the Directive. Products conforming with the MD Directive must have a CE mark applied. The Directive was most recently reviewed and amended by the 2007/47/EC and a number of changes were made. Compliance with the revised directive became mandatory on 21 March 2010.

A European Authorised Representative (E.A.R.) serves as a legal entity designated by non European Union (EU) manufacturers, to represent them in the EU and ensure their compliance with the European Directives. The CE certificate and declaration of conformity can only be issued by a company located in the European Union.

The Unique Device Identification (UDI) System is intended to assign a unique identifier to medical devices within the United States, Europe, China, South Korea, Saudi Arabia and Taiwan. It was signed into law in the US on September 27, 2007, as part of the Food and Drug Administration Amendments Act of 2007.

<span class="mw-page-title-main">Technischer Überwachungsverein</span> Independent service companies from Germany and Austria

TÜVs are internationally active, independent service companies from Germany and Austria that test, inspect and certify technical systems, facilities and objects of all kinds in order to minimize hazards and prevent damages. The TÜV companies are organized into three large holding companies, TÜV Nord, TÜV Rheinland and TÜV SÜD, along with the smaller independent companies TÜV Thüringen, TÜV Saarland and TÜV Austria.

<span class="mw-page-title-main">Regulation (EU) No. 305/2011</span>

Regulation No. 305/2011 of the European Parliament and of the Council of the European Union is a regulation of 9 March 2011 which lays down harmonised conditions for the marketing of construction products and replaces Construction Products Directive (89/106/EEC). This EU regulation is designed to simplify and clarify the existing framework for the placing on the market of construction products. It replaced the earlier (1989) Construction Products Directive (89/106/EEC).

<span class="mw-page-title-main">Poly Implant Prothèse</span>

Poly Implant Prothèse (PIP) was a French company founded in 1991 that produced silicone gel breast implants. The company was preemptively liquidated in 2010 following the revelation that they had been illegally manufacturing and selling breast implants made from cheaper industrial-grade silicone since 2001.

<span class="mw-page-title-main">FCC mark</span> Voluntary declaration of conformity

The FCC logo or the FCC mark is a voluntary mark employed on electronic products manufactured or sold in the United States which indicates that the electromagnetic radiation from the device is below the limits specified by the Federal Communications Commission and the manufacturer has followed the requirements of the Supplier's Declaration of Conformity authorization procedures. The FCC label is found even on products sold outside the US territory, because they are either products manufactured in the US and had been exported, or they are also sold in the US. This makes the FCC label recognizable worldwide even to people to whom the name of the agency is not familiar.

<span class="mw-page-title-main">Regulation (EU) 2017/745</span> Political regulation

Regulation (EU) 2017/745 is a regulation of the European Union on the clinical investigation and sale of medical devices for human use. It repeals Directive 93/42/EEC (MDD), which concerns medical devices, and Directive 90/385/EEC, which concerns active implantable medical devices, on 26 May 2021.

<span class="mw-page-title-main">Regulation (EU) 2017/746</span>

Regulation (EU) 2017/746 (IVDR) is a regulation of the European Union on the placing on the market and putting into service of in vitro diagnostic medical devices (IVD), repealing Directive 98/79/EC (IVDD), which also concerned IVD. The regulation was published in April 2017 and is closely aligned to the EU regulation on medical devices. Changes compared to the IVDD include changes in device classification, stricter oversight of manufacturers by Notified Bodies, introduction of the "Person Responsible for Regulatory Compliance" (PRRC), the requirement of UDI marking for devices, common specifications, Eudamed registration, and increased post-market surveillance activities.

A custom-made medical device, commonly referred to as a custom-made device (CMD) or a custom device, is a medical device designed and manufactured for the sole use of a particular patient. Examples of custom-made medical devices include auricular splints, dentures, orthodontic appliances, orthotics and prostheses.

References

  1. ↑ The 'Blue Guide' on the Implementation of EU Product Rules (PDF) (1.1 ed.). European Commission. 15 July 2015. p. 134. Retrieved 25 February 2016.
  2. 1 2 "Notified bodies". Growth: Internal Market, Industry, Entrepreneurship and SMEs. European Commission. 11 February 2016. Retrieved 25 February 2016.
  3. 1 2 Rudd-Clarke, P.; Page, F. (9 December 2015). "A product of our times". Insider Quarterly (Winter 2015). Archived from the original on 25 February 2016. Retrieved 25 February 2016.
  4. ↑ Medicines and Healthcare Products Regulatory Agency (November 2013). "Guidance on Legislation: Requirements for UK Notified Bodies" (PDF). Government of the U.K. p. 14. Retrieved 25 February 2016.
  5. ↑ Standards Office of the General Cooperation Council for the Arab States of the Gulf (26 November 2008). "Guide for Notified Bodies" (PDF). GCC Standardization Organization - GSO. p. 12. Archived from the original (PDF) on 1 April 2015. Retrieved 25 February 2016.
  6. 1 2 3 4 Noetel, K.-H. (11 September 2008). "Conformity assessment and notified bodies" (PDF). European Conference on Standardization, Testing and Certification. Retrieved 25 February 2016.
  7. 1 2 3 4 Chowdhury, N. (2014). "Chapter 6: Case Study on Medical Devices Regulation in Europe". European Regulation of Medical Devices and Pharmaceuticals: Regulatee Expectations of Legal Certainty. Cham, Switzerland: Springer International Publishing Switzerland. pp. 99–120. ISBN   9783319045948 . Retrieved 25 February 2016.
  8. ↑ Maxwell, A. (30 November 2009). "Tightening oversight of notified bodies: Enough to satisfy critics?". Clinica. Informa PLC. Retrieved 25 February 2016.[ permanent dead link ]
  9. 1 2 3 Shuren, J. (29 March 2012). "FDA User Fee Agreements: Strengthening FDA and the Medical Products Industry for the Benefit of Patients (JS)". Testimony. U.S. Food and Drug Administration. Retrieved 25 February 2016.
  10. ↑ Paravicini, G. (11 December 2015). "Breast implant, diesel cases expose lax EU oversight". Politico. Politico SPRL. Retrieved 26 February 2016.
  11. ↑ Love, B.; Flynn, D. (23 December 2011). "France, UK issue clashing advice on breast implants". Reuters. Thomson Reuters. Retrieved 25 February 2016.
  12. ↑ Clement, R. (November 2011). "Full Manufacturer Addresses on Medical Device Labels?". Consultants Corner. UBM Canon. Retrieved 25 February 2016.
  13. ↑ Eisenhart, S. (13 February 2012). "Tighter EU Regulatory Controls Proposed following PIP Controversy". Emergo Blog. Emergo Group. Retrieved 25 February 2016.
  14. ↑ Eisenhart, S. (23 October 2012). "Overview of new medical device regulations in Europe". Emergo Blog. Emergo Group. Retrieved 25 February 2016.
  15. ↑ Eisenhart, S. (30 November 2012). "European Commission Plans Greater Oversight of Notified Bodies". Emergo Blog. Emergo Group. Retrieved 25 February 2016.
  16. ↑ Montens, E.; Plasschaert, E. (22 May 2014). "PIP breast implants patients obtain a first 5,000,000 Euro victory against the Notified Body TUV Rheinland". Lexology. Globe Business Publishing Ltd. Retrieved 25 February 2016.
  17. ↑ Carbonnelle, N.; Martens, M.-P.; Goraya, T. (2 July 2015). "Medical device liability update". Bird & Bird News Centre. Bird & Bird. Retrieved 25 February 2016.
  18. ↑ Carbonnelle, N.; Martens, M.-P.; Thiénot, J.-B.; Goraya, T. (17 November 2015). "Medical devices liability update". Lexology. Globe Business Publishing Ltd. Retrieved 25 February 2016.
  19. ↑ "EUROPA - European Commission - Growth - Regulatory policy - NANDO".
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.